AP
Alnylam Pharmaceuticals, Inc. - Common Stock
ALNY
Close · 16/09/2026
239.36
1D
+0.46%52-week range
197.81 – 495.55
Volume
8,53,700.00
Price history
ALNY
17/08/2026 to 16/09/2026
O 239.50 H 242.24 L 236.00
1W-7.22%
1M+6.57%
3M-15.09%
6M-25.30%
1Y-48.09%
3Y+17.49%
5Y+28.47%
MAX+40.52%
Fundamentals
as of 16/09/2026- Market cap
- $32.03B
- Shares out
- 133.81M
- P/E (trailing)
- 41.34
- P/E (forward)
- 19.94
- EPS (trailing)
- 5.79
- Beta
- 0.30
- Profit margin
- 21.30%
- P/B
- 23.65
- Return on equity
- 57.21%
SEC financial statements
62 quarterly and 18 annual periods through 30/06/2026.
Details
- Ticker
- ALNY
- Index
- -
- Sector
- -
- Industry
- -
- HQ
- -
Last close 16/09/2026.
Tracked by Congress
5 filers · 1 on watchlist · 4 buys · 4 sells · ?: 3 · D: 4 · R: 1
- 11/08/2026Cory A BookerSellAlnylam Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 12/05/2025Jefferson ShreveSellAlnylam Pharmaceuticals, Inc. - Common Stock$15,001–$50,000
- 29/01/2024Josh GottheimerWSellAlnylam Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 11/01/2024Josh GottheimerWBuyAlnylam Pharmaceuticals, Inc. - Common Stock$1,001–$15,000
- 11/12/2023Josh GottheimerWSellAlnylam Pharmaceuticals, Inc.$1,001–$15,000
- 06/03/2023Daniel GoldmanBuyAlnylam Pharmaceuticals, Inc.$15,001–$50,000
- 28/09/2022Josh GottheimerWBuyAlnylam Pharmaceuticals, Inc.$1,001–$15,000
- 13/10/2016Richard L. HannaBuyAlnylam Pharmaceuticals, Inc. (ALNY) FILINg STATUS: New SUbHoLDINg oF: RHIRA$100,001–$250,000